LOC100240734: A Drug Target / Disease Biomarker (G100240734)

Target Name: LOC100240734

NCBI ID: G100240734

LOC100240734

Other Name(s): Uncharacterized LOC100240734 | uncharacterized LOC100240734

LOC100240734: A Drug Target / Disease Biomarker

LOC100240734 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the T-cell receptor (TCR) family, which is a critical regulator of immune responses.

The TCR is composed of a variable region and a constant region. The variable region is responsible for recognizing specific antigens, while the constant region provides structural stability to the TCR. LOC100240734 is a constant region protein that is characterized by a single open reading frame (ORF) that contains 25 amino acid residues.

One of the unique features of LOC100240734 is its gene structure. It has a single exon that is located at position -629 on the human chromosome. This means that it is a single-exon protein that is encoded from the same gene as another protein called ORF21.

LC0072 is a cell-surface antigen that is expressed in various tissues of the body, including the brain, spleen, and Peyer's patches. It is a type-I transmembrane protein that consists of a single extracellular domain and a single intracellular domain. The extracellular domain is responsible for cell adhesion and interactions, while the intracellular domain is involved in the regulation of cellular processes such as cell growth and differentiation.

LC0072 is also known as CD11b, which is a cell adhesion molecule that is expressed in various tissues of the body, including the brain. It is a type-I transmembrane protein that consists of a single extracellular domain and a single intracellular domain. The extracellular domain is responsible for cell adhesion and interactions, while the intracellular domain is involved in the regulation of cellular processes such as cell growth and differentiation.

LC0072 has been shown to be involved in various cellular processes, including the regulation of inflammation and immune responses. It has been shown to play a role in the development of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

In addition to its role in cellular processes, LOC100240734 has also been shown to be involved in the regulation of cellular interactions and communications. It is a type-I transmembrane protein that is involved in cell-cell and cell-tissue interactions, as well as in cell-cell signaling pathways.

LC0072 has also been shown to be involved in the regulation of inflammation and immune responses. It has been shown to play a role in the development of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

In addition to its role in cellular processes and interactions, LOC100240734 has also been shown to be involved in the regulation of gene expression. It is a type-I transmembrane protein that is involved in the regulation of gene expression by intracellular signaling pathways, including the TCR signaling pathway.

In conclusion, LOC100240734 is a protein that is expressed in various tissues of the body and is involved in various cellular processes, including the regulation of cell adhesion and interactions, the regulation of inflammation and immune responses, and the regulation of gene expression. Its unique gene structure and involvement in cellular interactions and communications make it an attractive drug target or biomarker for future research. Further studies are needed to fully understand its role in various biological processes and to develop effective treatments for diseases associated with its dysfunction.

Protein Name: Uncharacterized LOC100240734

The "LOC100240734 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100240734 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.tech.

More Common Targets